Antileukemic Activity and Tolerability of ASP2215 80mg and Greater in FLT3 Mutation-Positive Subjects with Relapsed or Refractory Acute Myeloid Leukemia: Results from a Phase 1/2, Open-Label, Dose-Escalation/Dose-Response Study


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Altman, JK; Perl, AE; Cortes, JE; Levis, MJ; Smith, CC; Litzow, MR; Baer, MR; Claxton, DF; Erba, HP; Gill, SC; Goldberg, SL; Jurcic, JG; Larson, RA; Lui, C; Ritchie, EK; Sargent, B; Schiller, GJ; Spira, AI; Strickland, SA; Tibes, R; Ustun, C; Wang, ES; Stuart, RK; Baldus, CD; Rollig, C; Neubauer, A; Martinelli, G; Bahceci, E

Published Date

  • December 3, 2015

Published In

Volume / Issue

  • 126 / 23

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 57th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • Orlando, FL

Conference Start Date

  • December 5, 2015

Conference End Date

  • December 8, 2015